In contrast to breast tumors associated with BRCA1, lack of caveolin-1 expression in breast tumors has been reported in patients with germline mutations in BRCA2, suggesting that the expression of caveolin-1 occurs only in tumors with mutations in BRCA1 (Pinilla et al., 2006). This evidence concerns the gene BRCA2 and breast neoplasm.